SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024971
Filing Date
2022-11-14
Accepted
2022-11-14 16:04:08
Documents
80
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-20220930.htm   iXBRL 10-Q 4080556
2 EX-10.1 spro-ex10_1.htm EX-10.1 21634
3 EX-10.3 spro-ex10_3.htm EX-10.3 1617544
4 EX-10.4 spro-ex10_4.htm EX-10.4 315214
5 EX-10.5 spro-ex10_5.htm EX-10.5 179624
6 EX-10.6 spro-ex10_6.htm EX-10.6 30910
7 EX-10.7 spro-ex10_7.htm EX-10.7 31050
8 EX-10.8 spro-ex10_8.htm EX-10.8 27621
9 EX-10.9 spro-ex10_9.htm EX-10.9 30883
10 EX-10.10 spro-ex10_10.htm EX-10.10 31219
11 EX-31.1 spro-ex31_1.htm EX-31.1 13176
12 EX-31.2 spro-ex31_2.htm EX-31.2 13205
13 EX-32 spro-ex32.htm EX-32 11976
  Complete submission text file 0000950170-22-024971.txt   15173946

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT spro-20220930_cal.xml EX-101.CAL 46478
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT spro-20220930_lab.xml EX-101.LAB 606105
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT spro-20220930_def.xml EX-101.DEF 333560
17 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT spro-20220930.xsd EX-101.SCH 89045
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT spro-20220930_pre.xml EX-101.PRE 491894
74 EXTRACTED XBRL INSTANCE DOCUMENT spro-20220930_htm.xml XML 2233124
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 221385016
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences